Skip to main content
. 2013 Aug 4;121(1):29–31. doi: 10.1007/s00702-013-1076-z

Fig. 1.

Fig. 1

Interinjection intervals and treatment durations of all 40 patients studied. Only data points deriving from four or more patients are included. The bar indicates the time when Botox® treatments were switched to Xeomin® treatments using a 1:1 conversion ratio. M+SD mean plus standard deviation, M-SD mean minus standard deviation